David Tsai Available Now

David Tsai is Pillsbury Winthrop Shaw Pittman LLP’s Taiwan practice co-leader and also a partner in the San Francisco office. David is a first-chair trial lawyer and focuses his practice on intellectual property, patent, trade secret, trademark, copyright, complex breach of contract and product defect litigation in courts and international arbitration tribunals. David represents world-class corporations innovating biotechnology, pharmaceuticals, medical devices, software (AI, internet and mobile apps) and hardware (semiconductors, set-top boxes, smartphones, solar wafers and light-emitting diodes/LED/OLED). In addition to litigation, his experience includes preparing and prosecuting U.S. electrical engineering patent applications, drafting patentability, freedom-to-operate and non-infringement opinions, as well as inter partes review (IPR) petitions. He advises his clients in patent negotiations, licensing, M&A transactions and overall intellectual property strategy. David has been quoted in various business and technology publications, including The New York Times, and has written and lectured internationally on Hatch-Waxman/Abbreviated New Drug Application (ANDA) litigation, standard essential patents, FRAND/RAND royalties, internet software applications and U.S. patent law. In 2017 − 2019, he served as one of the 18 lawyer representatives to the United States District Court, Northern District of California. He has also served on the Executive Committee of the Board of Trustees for the University of California, Riverside (UCR), Foundation and currently serves on the Advisory Board of Santa Clara University School of Law. He is the immediate past president of the Harvard Club of San Francisco and a past president of the Silicon Valley IP Law Association (SVIPLA) and the Asian American Bar Association of the Greater Bay Area (AABA). In 2016, David was recognized by the California State Legislature for his work in civil rights.